Gabriela Fonseca Lopes , Paula Brumana Corrêa , Fernando Luiz Pereira de Oliveira , Nathalia Sernizon Guimarães , Nícia Pedreira Soares , Andrea Yukie Arikawa , Aline da Silva Miranda de Menezes e Souza , Rachel Basques Caligiorne , Luciana Araújo Marques , Nancy Scardua Binda , Sônia Maria de Figueiredo
{"title":"巴西绿蜂胶对糖尿病患者生化指标及饮食摄入的影响。","authors":"Gabriela Fonseca Lopes , Paula Brumana Corrêa , Fernando Luiz Pereira de Oliveira , Nathalia Sernizon Guimarães , Nícia Pedreira Soares , Andrea Yukie Arikawa , Aline da Silva Miranda de Menezes e Souza , Rachel Basques Caligiorne , Luciana Araújo Marques , Nancy Scardua Binda , Sônia Maria de Figueiredo","doi":"10.1016/j.diabres.2025.112236","DOIUrl":null,"url":null,"abstract":"<div><div><strong><em>Objective:</em></strong> To evaluate the effect of dietary supplementation with Brazilian green propolis-BrGrProp on biochemical parameters and dietary intake in People Living with Diabetes − PLWD. <strong><em>Method:</em></strong> Randomized double-blind study performed for thirty days. PLWD (n = 62/Phase-1: PLWD supplemented with BrGrProp (<strong>G1/</strong>n = 31) and another treated with <em>Manihot esculenta</em> starch (Placebo/n = 31). From this group, 22 PLWD (<strong>G2</strong>) participated in the study being treated with BrGrProp, characterized as Phase-2. PLWD received capsules (2× 500 mg/day) of BrGrProp or Placebo. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol and fractions, pyruvic glutamic transaminase, oxalacetic glutamic transaminase, gamma glutamyl transferase, and dietary intake data were determined at the beginning and end of the study. Statistical analysis was performed using the SPSS 21/Minitab-17/Prisma 7.0. <strong><em>Results:</em></strong> Phase-1: no significant changes were observed in the analyzed parameters. Phase 2: Improvement in glycemic parameters (FBG and HbA1c) and most lipid parameters (TC, LDL, HDL and TG), with reduction in the level of Hb1Ac (p = 0.023), increase in the level of HDL (p = 0.048) and in the food intake of the PLWD. The indicators of liver function did not show significant changes. <strong><em>Conclusion:</em></strong> BrGrProp in the diet generates beneficial effects for diabetics, characterized by improvement of HbA1c and HDL parameters, without causing detectable harmful changes.</div></div>","PeriodicalId":11249,"journal":{"name":"Diabetes research and clinical practice","volume":"225 ","pages":"Article 112236"},"PeriodicalIF":6.1000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Brazilian green propolis effect on biochemical parameters and dietary intake in people living with diabetes\",\"authors\":\"Gabriela Fonseca Lopes , Paula Brumana Corrêa , Fernando Luiz Pereira de Oliveira , Nathalia Sernizon Guimarães , Nícia Pedreira Soares , Andrea Yukie Arikawa , Aline da Silva Miranda de Menezes e Souza , Rachel Basques Caligiorne , Luciana Araújo Marques , Nancy Scardua Binda , Sônia Maria de Figueiredo\",\"doi\":\"10.1016/j.diabres.2025.112236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div><strong><em>Objective:</em></strong> To evaluate the effect of dietary supplementation with Brazilian green propolis-BrGrProp on biochemical parameters and dietary intake in People Living with Diabetes − PLWD. <strong><em>Method:</em></strong> Randomized double-blind study performed for thirty days. PLWD (n = 62/Phase-1: PLWD supplemented with BrGrProp (<strong>G1/</strong>n = 31) and another treated with <em>Manihot esculenta</em> starch (Placebo/n = 31). From this group, 22 PLWD (<strong>G2</strong>) participated in the study being treated with BrGrProp, characterized as Phase-2. PLWD received capsules (2× 500 mg/day) of BrGrProp or Placebo. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol and fractions, pyruvic glutamic transaminase, oxalacetic glutamic transaminase, gamma glutamyl transferase, and dietary intake data were determined at the beginning and end of the study. Statistical analysis was performed using the SPSS 21/Minitab-17/Prisma 7.0. <strong><em>Results:</em></strong> Phase-1: no significant changes were observed in the analyzed parameters. Phase 2: Improvement in glycemic parameters (FBG and HbA1c) and most lipid parameters (TC, LDL, HDL and TG), with reduction in the level of Hb1Ac (p = 0.023), increase in the level of HDL (p = 0.048) and in the food intake of the PLWD. The indicators of liver function did not show significant changes. <strong><em>Conclusion:</em></strong> BrGrProp in the diet generates beneficial effects for diabetics, characterized by improvement of HbA1c and HDL parameters, without causing detectable harmful changes.</div></div>\",\"PeriodicalId\":11249,\"journal\":{\"name\":\"Diabetes research and clinical practice\",\"volume\":\"225 \",\"pages\":\"Article 112236\"},\"PeriodicalIF\":6.1000,\"publicationDate\":\"2025-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetes research and clinical practice\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168822725002505\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes research and clinical practice","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168822725002505","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Brazilian green propolis effect on biochemical parameters and dietary intake in people living with diabetes
Objective: To evaluate the effect of dietary supplementation with Brazilian green propolis-BrGrProp on biochemical parameters and dietary intake in People Living with Diabetes − PLWD. Method: Randomized double-blind study performed for thirty days. PLWD (n = 62/Phase-1: PLWD supplemented with BrGrProp (G1/n = 31) and another treated with Manihot esculenta starch (Placebo/n = 31). From this group, 22 PLWD (G2) participated in the study being treated with BrGrProp, characterized as Phase-2. PLWD received capsules (2× 500 mg/day) of BrGrProp or Placebo. Fasting blood glucose, glycated hemoglobin (HbA1c), total cholesterol and fractions, pyruvic glutamic transaminase, oxalacetic glutamic transaminase, gamma glutamyl transferase, and dietary intake data were determined at the beginning and end of the study. Statistical analysis was performed using the SPSS 21/Minitab-17/Prisma 7.0. Results: Phase-1: no significant changes were observed in the analyzed parameters. Phase 2: Improvement in glycemic parameters (FBG and HbA1c) and most lipid parameters (TC, LDL, HDL and TG), with reduction in the level of Hb1Ac (p = 0.023), increase in the level of HDL (p = 0.048) and in the food intake of the PLWD. The indicators of liver function did not show significant changes. Conclusion: BrGrProp in the diet generates beneficial effects for diabetics, characterized by improvement of HbA1c and HDL parameters, without causing detectable harmful changes.
期刊介绍:
Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.